IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition’s pathogenesis.
Novel gene therapy PS-002 targets podocytes in IgA nephropathy
- Post author:
- Post published:October 27, 2024
- Post category:uncategorized
- Post comments:0 Comments